nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Benazepril—hypertension	0.445	1	CrCtD
Solifenacin—Benazepril—Moexipril—hypertension	0.0508	0.202	CrCrCtD
Solifenacin—Benazepril—Quinapril—hypertension	0.0421	0.167	CrCrCtD
Solifenacin—Benazepril—Labetalol—hypertension	0.0364	0.144	CrCrCtD
Solifenacin—Benazepril—Enalapril—hypertension	0.0347	0.138	CrCrCtD
Solifenacin—Benazepril—Trandolapril—hypertension	0.0347	0.138	CrCrCtD
Solifenacin—Benazepril—Lisinopril—hypertension	0.0271	0.108	CrCrCtD
Solifenacin—Benazepril—Ramipril—hypertension	0.0263	0.104	CrCrCtD
Solifenacin—CHRM4—Nicardipine—hypertension	0.024	0.152	CbGbCtD
Solifenacin—CHRM5—Nicardipine—hypertension	0.0234	0.149	CbGbCtD
Solifenacin—CHRM3—Nicardipine—hypertension	0.015	0.0949	CbGbCtD
Solifenacin—CHRM1—Nicardipine—hypertension	0.013	0.0826	CbGbCtD
Solifenacin—CHRM2—Nicardipine—hypertension	0.012	0.0761	CbGbCtD
Solifenacin—CYP3A4—Guanethidine—hypertension	0.00777	0.0492	CbGbCtD
Solifenacin—CYP3A4—Hydralazine—hypertension	0.00589	0.0373	CbGbCtD
Solifenacin—CYP3A4—Guanfacine—hypertension	0.005	0.0317	CbGbCtD
Solifenacin—CYP3A4—Isradipine—hypertension	0.00446	0.0283	CbGbCtD
Solifenacin—CYP3A4—Indapamide—hypertension	0.00393	0.0249	CbGbCtD
Solifenacin—CYP3A4—Nisoldipine—hypertension	0.00393	0.0249	CbGbCtD
Solifenacin—CYP3A4—Eplerenone—hypertension	0.00379	0.024	CbGbCtD
Solifenacin—CYP3A4—Diltiazem—hypertension	0.00379	0.024	CbGbCtD
Solifenacin—CYP3A4—Enalapril—hypertension	0.00338	0.0214	CbGbCtD
Solifenacin—CYP3A4—Irbesartan—hypertension	0.00309	0.0196	CbGbCtD
Solifenacin—CYP3A4—Amlodipine—hypertension	0.00303	0.0192	CbGbCtD
Solifenacin—CYP3A4—Felodipine—hypertension	0.00292	0.0185	CbGbCtD
Solifenacin—CYP3A4—Nifedipine—hypertension	0.00283	0.0179	CbGbCtD
Solifenacin—CYP3A4—Carvedilol—hypertension	0.00278	0.0177	CbGbCtD
Solifenacin—CYP3A4—Nicardipine—hypertension	0.00278	0.0177	CbGbCtD
Solifenacin—CYP3A4—Propranolol—hypertension	0.00256	0.0162	CbGbCtD
Solifenacin—CYP3A4—Clonidine—hypertension	0.00244	0.0155	CbGbCtD
Solifenacin—CYP3A4—Atorvastatin—hypertension	0.00218	0.0138	CbGbCtD
Solifenacin—CYP3A4—Losartan—hypertension	0.00199	0.0126	CbGbCtD
Solifenacin—CYP3A4—Verapamil—hypertension	0.00176	0.0111	CbGbCtD
Solifenacin—Benazepril—MTHFR—hypertension	0.00034	0.551	CrCbGaD
Solifenacin—Benazepril—ACE—hypertension	0.000277	0.449	CrCbGaD
Solifenacin—Constipation—Betaxolol—hypertension	2.16e-05	0.000232	CcSEcCtD
Solifenacin—Feeling abnormal—Irbesartan—hypertension	2.15e-05	0.000231	CcSEcCtD
Solifenacin—Headache—Diltiazem—hypertension	2.15e-05	0.000231	CcSEcCtD
Solifenacin—Headache—Indapamide—hypertension	2.15e-05	0.000231	CcSEcCtD
Solifenacin—Pruritus—Valsartan—hypertension	2.15e-05	0.000231	CcSEcCtD
Solifenacin—Dry mouth—Ramipril—hypertension	2.15e-05	0.000231	CcSEcCtD
Solifenacin—Rash—Carvedilol—hypertension	2.14e-05	0.000231	CcSEcCtD
Solifenacin—Gastrointestinal pain—Perindopril—hypertension	2.14e-05	0.00023	CcSEcCtD
Solifenacin—Dermatitis—Carvedilol—hypertension	2.14e-05	0.00023	CcSEcCtD
Solifenacin—Angioedema—Lisinopril—hypertension	2.14e-05	0.00023	CcSEcCtD
Solifenacin—Pruritus—Olmesartan—hypertension	2.14e-05	0.00023	CcSEcCtD
Solifenacin—Vomiting—Doxazosin—hypertension	2.14e-05	0.00023	CcSEcCtD
Solifenacin—Decreased appetite—Losartan—hypertension	2.14e-05	0.00023	CcSEcCtD
Solifenacin—Gastrointestinal pain—Irbesartan—hypertension	2.14e-05	0.00023	CcSEcCtD
Solifenacin—Feeling abnormal—Hydrochlorothiazide—hypertension	2.13e-05	0.00023	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	2.13e-05	0.00023	CcSEcCtD
Solifenacin—Hypersensitivity—Clonidine—hypertension	2.13e-05	0.00023	CcSEcCtD
Solifenacin—Abdominal pain—Captopril—hypertension	2.13e-05	0.000229	CcSEcCtD
Solifenacin—Headache—Carvedilol—hypertension	2.13e-05	0.000229	CcSEcCtD
Solifenacin—Confusional state—Ramipril—hypertension	2.13e-05	0.000229	CcSEcCtD
Solifenacin—Rash—Doxazosin—hypertension	2.12e-05	0.000228	CcSEcCtD
Solifenacin—Fatigue—Losartan—hypertension	2.12e-05	0.000228	CcSEcCtD
Solifenacin—Dermatitis—Doxazosin—hypertension	2.12e-05	0.000228	CcSEcCtD
Solifenacin—Gastrointestinal pain—Hydrochlorothiazide—hypertension	2.12e-05	0.000228	CcSEcCtD
Solifenacin—Vomiting—Fosinopril—hypertension	2.11e-05	0.000227	CcSEcCtD
Solifenacin—Nausea—Propranolol—hypertension	2.11e-05	0.000227	CcSEcCtD
Solifenacin—Anaphylactic shock—Ramipril—hypertension	2.11e-05	0.000227	CcSEcCtD
Solifenacin—Headache—Doxazosin—hypertension	2.11e-05	0.000227	CcSEcCtD
Solifenacin—Dry mouth—Timolol—hypertension	2.1e-05	0.000226	CcSEcCtD
Solifenacin—Constipation—Losartan—hypertension	2.1e-05	0.000226	CcSEcCtD
Solifenacin—Vomiting—Eplerenone—hypertension	2.1e-05	0.000226	CcSEcCtD
Solifenacin—Feeling abnormal—Furosemide—hypertension	2.1e-05	0.000226	CcSEcCtD
Solifenacin—Rash—Fosinopril—hypertension	2.1e-05	0.000225	CcSEcCtD
Solifenacin—Dermatitis—Fosinopril—hypertension	2.09e-05	0.000225	CcSEcCtD
Solifenacin—Vomiting—Nifedipine—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Gastrointestinal pain—Furosemide—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Rash—Eplerenone—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Urticaria—Perindopril—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Headache—Fosinopril—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Hypersensitivity—Trandolapril—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Dermatitis—Eplerenone—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Asthenia—Clonidine—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Feeling abnormal—Betaxolol—hypertension	2.08e-05	0.000224	CcSEcCtD
Solifenacin—Confusional state—Timolol—hypertension	2.08e-05	0.000223	CcSEcCtD
Solifenacin—Vomiting—Verapamil—hypertension	2.08e-05	0.000223	CcSEcCtD
Solifenacin—Urticaria—Irbesartan—hypertension	2.07e-05	0.000223	CcSEcCtD
Solifenacin—Hypersensitivity—Enalapril—hypertension	2.07e-05	0.000223	CcSEcCtD
Solifenacin—Abdominal pain—Perindopril—hypertension	2.07e-05	0.000223	CcSEcCtD
Solifenacin—Palpitations—Lisinopril—hypertension	2.07e-05	0.000223	CcSEcCtD
Solifenacin—Headache—Eplerenone—hypertension	2.07e-05	0.000223	CcSEcCtD
Solifenacin—Rash—Nifedipine—hypertension	2.07e-05	0.000222	CcSEcCtD
Solifenacin—Nervous system disorder—Ramipril—hypertension	2.07e-05	0.000222	CcSEcCtD
Solifenacin—Dermatitis—Nifedipine—hypertension	2.07e-05	0.000222	CcSEcCtD
Solifenacin—Abdominal pain—Irbesartan—hypertension	2.06e-05	0.000222	CcSEcCtD
Solifenacin—Anaphylactic shock—Timolol—hypertension	2.06e-05	0.000222	CcSEcCtD
Solifenacin—Rash—Verapamil—hypertension	2.06e-05	0.000221	CcSEcCtD
Solifenacin—Urticaria—Hydrochlorothiazide—hypertension	2.06e-05	0.000221	CcSEcCtD
Solifenacin—Tachycardia—Ramipril—hypertension	2.06e-05	0.000221	CcSEcCtD
Solifenacin—Dermatitis—Verapamil—hypertension	2.06e-05	0.000221	CcSEcCtD
Solifenacin—Headache—Nifedipine—hypertension	2.05e-05	0.000221	CcSEcCtD
Solifenacin—Pruritus—Clonidine—hypertension	2.05e-05	0.00022	CcSEcCtD
Solifenacin—Abdominal pain—Hydrochlorothiazide—hypertension	2.05e-05	0.00022	CcSEcCtD
Solifenacin—Skin disorder—Ramipril—hypertension	2.05e-05	0.00022	CcSEcCtD
Solifenacin—Infection—Timolol—hypertension	2.05e-05	0.00022	CcSEcCtD
Solifenacin—Headache—Verapamil—hypertension	2.04e-05	0.00022	CcSEcCtD
Solifenacin—Hypersensitivity—Telmisartan—hypertension	2.04e-05	0.00022	CcSEcCtD
Solifenacin—Cough—Lisinopril—hypertension	2.04e-05	0.00022	CcSEcCtD
Solifenacin—Nausea—Indapamide—hypertension	2.04e-05	0.000219	CcSEcCtD
Solifenacin—Nausea—Diltiazem—hypertension	2.04e-05	0.000219	CcSEcCtD
Solifenacin—Asthenia—Trandolapril—hypertension	2.03e-05	0.000218	CcSEcCtD
Solifenacin—Feeling abnormal—Losartan—hypertension	2.03e-05	0.000218	CcSEcCtD
Solifenacin—Urticaria—Furosemide—hypertension	2.02e-05	0.000218	CcSEcCtD
Solifenacin—Nervous system disorder—Timolol—hypertension	2.02e-05	0.000217	CcSEcCtD
Solifenacin—Nausea—Carvedilol—hypertension	2.02e-05	0.000217	CcSEcCtD
Solifenacin—Asthenia—Enalapril—hypertension	2.02e-05	0.000217	CcSEcCtD
Solifenacin—Abdominal pain—Furosemide—hypertension	2.01e-05	0.000217	CcSEcCtD
Solifenacin—Gastrointestinal pain—Losartan—hypertension	2.01e-05	0.000216	CcSEcCtD
Solifenacin—Dizziness—Valsartan—hypertension	2.01e-05	0.000216	CcSEcCtD
Solifenacin—Urticaria—Betaxolol—hypertension	2e-05	0.000215	CcSEcCtD
Solifenacin—Skin disorder—Timolol—hypertension	2e-05	0.000215	CcSEcCtD
Solifenacin—Dizziness—Olmesartan—hypertension	2e-05	0.000215	CcSEcCtD
Solifenacin—Pruritus—Trandolapril—hypertension	2e-05	0.000215	CcSEcCtD
Solifenacin—Nausea—Doxazosin—hypertension	2e-05	0.000215	CcSEcCtD
Solifenacin—Asthenia—Telmisartan—hypertension	1.99e-05	0.000214	CcSEcCtD
Solifenacin—Pruritus—Enalapril—hypertension	1.99e-05	0.000214	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.98e-05	0.000213	CcSEcCtD
Solifenacin—Nausea—Fosinopril—hypertension	1.97e-05	0.000212	CcSEcCtD
Solifenacin—Pruritus—Telmisartan—hypertension	1.96e-05	0.000211	CcSEcCtD
Solifenacin—Nausea—Eplerenone—hypertension	1.96e-05	0.000211	CcSEcCtD
Solifenacin—Urticaria—Losartan—hypertension	1.95e-05	0.00021	CcSEcCtD
Solifenacin—Dry mouth—Lisinopril—hypertension	1.95e-05	0.00021	CcSEcCtD
Solifenacin—Nausea—Nifedipine—hypertension	1.95e-05	0.000209	CcSEcCtD
Solifenacin—Abdominal pain—Losartan—hypertension	1.94e-05	0.000209	CcSEcCtD
Solifenacin—Nausea—Verapamil—hypertension	1.94e-05	0.000209	CcSEcCtD
Solifenacin—Asthenia—Captopril—hypertension	1.94e-05	0.000208	CcSEcCtD
Solifenacin—Vomiting—Valsartan—hypertension	1.93e-05	0.000208	CcSEcCtD
Solifenacin—Confusional state—Lisinopril—hypertension	1.93e-05	0.000207	CcSEcCtD
Solifenacin—Hypersensitivity—Irbesartan—hypertension	1.92e-05	0.000207	CcSEcCtD
Solifenacin—Vomiting—Olmesartan—hypertension	1.92e-05	0.000207	CcSEcCtD
Solifenacin—Rash—Valsartan—hypertension	1.92e-05	0.000206	CcSEcCtD
Solifenacin—Dizziness—Clonidine—hypertension	1.92e-05	0.000206	CcSEcCtD
Solifenacin—Dermatitis—Valsartan—hypertension	1.91e-05	0.000206	CcSEcCtD
Solifenacin—Anaphylactic shock—Lisinopril—hypertension	1.91e-05	0.000206	CcSEcCtD
Solifenacin—Pruritus—Captopril—hypertension	1.91e-05	0.000205	CcSEcCtD
Solifenacin—Hypersensitivity—Hydrochlorothiazide—hypertension	1.91e-05	0.000205	CcSEcCtD
Solifenacin—Rash—Olmesartan—hypertension	1.91e-05	0.000205	CcSEcCtD
Solifenacin—Dermatitis—Olmesartan—hypertension	1.91e-05	0.000205	CcSEcCtD
Solifenacin—Headache—Valsartan—hypertension	1.9e-05	0.000205	CcSEcCtD
Solifenacin—Infection—Lisinopril—hypertension	1.9e-05	0.000204	CcSEcCtD
Solifenacin—Headache—Olmesartan—hypertension	1.89e-05	0.000204	CcSEcCtD
Solifenacin—Asthenia—Perindopril—hypertension	1.88e-05	0.000202	CcSEcCtD
Solifenacin—Hypersensitivity—Furosemide—hypertension	1.88e-05	0.000202	CcSEcCtD
Solifenacin—Asthenia—Irbesartan—hypertension	1.87e-05	0.000202	CcSEcCtD
Solifenacin—Somnolence—Ramipril—hypertension	1.87e-05	0.000202	CcSEcCtD
Solifenacin—Dizziness—Trandolapril—hypertension	1.87e-05	0.000201	CcSEcCtD
Solifenacin—Tachycardia—Lisinopril—hypertension	1.87e-05	0.000201	CcSEcCtD
Solifenacin—Dizziness—Enalapril—hypertension	1.86e-05	0.0002	CcSEcCtD
Solifenacin—Asthenia—Hydrochlorothiazide—hypertension	1.86e-05	0.0002	CcSEcCtD
Solifenacin—Hypersensitivity—Betaxolol—hypertension	1.86e-05	0.0002	CcSEcCtD
Solifenacin—Skin disorder—Lisinopril—hypertension	1.86e-05	0.0002	CcSEcCtD
Solifenacin—Dyspepsia—Ramipril—hypertension	1.86e-05	0.0002	CcSEcCtD
Solifenacin—Pruritus—Perindopril—hypertension	1.85e-05	0.000199	CcSEcCtD
Solifenacin—Pruritus—Irbesartan—hypertension	1.85e-05	0.000199	CcSEcCtD
Solifenacin—Vomiting—Clonidine—hypertension	1.84e-05	0.000198	CcSEcCtD
Solifenacin—Dizziness—Telmisartan—hypertension	1.84e-05	0.000197	CcSEcCtD
Solifenacin—Pruritus—Hydrochlorothiazide—hypertension	1.83e-05	0.000197	CcSEcCtD
Solifenacin—Decreased appetite—Ramipril—hypertension	1.83e-05	0.000197	CcSEcCtD
Solifenacin—Somnolence—Timolol—hypertension	1.83e-05	0.000197	CcSEcCtD
Solifenacin—Asthenia—Furosemide—hypertension	1.83e-05	0.000197	CcSEcCtD
Solifenacin—Rash—Clonidine—hypertension	1.83e-05	0.000196	CcSEcCtD
Solifenacin—Dermatitis—Clonidine—hypertension	1.82e-05	0.000196	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Ramipril—hypertension	1.82e-05	0.000196	CcSEcCtD
Solifenacin—Fatigue—Ramipril—hypertension	1.82e-05	0.000195	CcSEcCtD
Solifenacin—Headache—Clonidine—hypertension	1.81e-05	0.000195	CcSEcCtD
Solifenacin—Dyspepsia—Timolol—hypertension	1.81e-05	0.000195	CcSEcCtD
Solifenacin—Hypersensitivity—Losartan—hypertension	1.81e-05	0.000195	CcSEcCtD
Solifenacin—Asthenia—Betaxolol—hypertension	1.81e-05	0.000195	CcSEcCtD
Solifenacin—Nausea—Valsartan—hypertension	1.81e-05	0.000194	CcSEcCtD
Solifenacin—Pruritus—Furosemide—hypertension	1.8e-05	0.000194	CcSEcCtD
Solifenacin—Constipation—Ramipril—hypertension	1.8e-05	0.000194	CcSEcCtD
Solifenacin—Nausea—Olmesartan—hypertension	1.8e-05	0.000193	CcSEcCtD
Solifenacin—Vomiting—Trandolapril—hypertension	1.8e-05	0.000193	CcSEcCtD
Solifenacin—Decreased appetite—Timolol—hypertension	1.79e-05	0.000193	CcSEcCtD
Solifenacin—Vomiting—Enalapril—hypertension	1.79e-05	0.000192	CcSEcCtD
Solifenacin—Dizziness—Captopril—hypertension	1.78e-05	0.000192	CcSEcCtD
Solifenacin—Pruritus—Betaxolol—hypertension	1.78e-05	0.000192	CcSEcCtD
Solifenacin—Rash—Trandolapril—hypertension	1.78e-05	0.000192	CcSEcCtD
Solifenacin—Dermatitis—Trandolapril—hypertension	1.78e-05	0.000191	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Timolol—hypertension	1.78e-05	0.000191	CcSEcCtD
Solifenacin—Fatigue—Timolol—hypertension	1.78e-05	0.000191	CcSEcCtD
Solifenacin—Rash—Enalapril—hypertension	1.77e-05	0.000191	CcSEcCtD
Solifenacin—Dermatitis—Enalapril—hypertension	1.77e-05	0.000191	CcSEcCtD
Solifenacin—Headache—Trandolapril—hypertension	1.77e-05	0.00019	CcSEcCtD
Solifenacin—Vomiting—Telmisartan—hypertension	1.76e-05	0.00019	CcSEcCtD
Solifenacin—Asthenia—Losartan—hypertension	1.76e-05	0.00019	CcSEcCtD
Solifenacin—Headache—Enalapril—hypertension	1.76e-05	0.00019	CcSEcCtD
Solifenacin—Rash—Telmisartan—hypertension	1.75e-05	0.000188	CcSEcCtD
Solifenacin—Dermatitis—Telmisartan—hypertension	1.75e-05	0.000188	CcSEcCtD
Solifenacin—Pruritus—Losartan—hypertension	1.74e-05	0.000187	CcSEcCtD
Solifenacin—Headache—Telmisartan—hypertension	1.74e-05	0.000187	CcSEcCtD
Solifenacin—Feeling abnormal—Ramipril—hypertension	1.74e-05	0.000187	CcSEcCtD
Solifenacin—Dizziness—Perindopril—hypertension	1.73e-05	0.000186	CcSEcCtD
Solifenacin—Dizziness—Irbesartan—hypertension	1.73e-05	0.000186	CcSEcCtD
Solifenacin—Gastrointestinal pain—Ramipril—hypertension	1.72e-05	0.000185	CcSEcCtD
Solifenacin—Nausea—Clonidine—hypertension	1.72e-05	0.000185	CcSEcCtD
Solifenacin—Vomiting—Captopril—hypertension	1.72e-05	0.000185	CcSEcCtD
Solifenacin—Dizziness—Hydrochlorothiazide—hypertension	1.71e-05	0.000184	CcSEcCtD
Solifenacin—Rash—Captopril—hypertension	1.7e-05	0.000183	CcSEcCtD
Solifenacin—Dermatitis—Captopril—hypertension	1.7e-05	0.000183	CcSEcCtD
Solifenacin—Somnolence—Lisinopril—hypertension	1.7e-05	0.000183	CcSEcCtD
Solifenacin—Feeling abnormal—Timolol—hypertension	1.7e-05	0.000183	CcSEcCtD
Solifenacin—Headache—Captopril—hypertension	1.69e-05	0.000182	CcSEcCtD
Solifenacin—Gastrointestinal pain—Timolol—hypertension	1.68e-05	0.000181	CcSEcCtD
Solifenacin—Dizziness—Furosemide—hypertension	1.68e-05	0.000181	CcSEcCtD
Solifenacin—Dyspepsia—Lisinopril—hypertension	1.68e-05	0.000181	CcSEcCtD
Solifenacin—Nausea—Trandolapril—hypertension	1.68e-05	0.00018	CcSEcCtD
Solifenacin—Urticaria—Ramipril—hypertension	1.67e-05	0.00018	CcSEcCtD
Solifenacin—Nausea—Enalapril—hypertension	1.67e-05	0.00018	CcSEcCtD
Solifenacin—Dizziness—Betaxolol—hypertension	1.67e-05	0.000179	CcSEcCtD
Solifenacin—Vomiting—Perindopril—hypertension	1.67e-05	0.000179	CcSEcCtD
Solifenacin—Abdominal pain—Ramipril—hypertension	1.67e-05	0.000179	CcSEcCtD
Solifenacin—Decreased appetite—Lisinopril—hypertension	1.66e-05	0.000179	CcSEcCtD
Solifenacin—Vomiting—Irbesartan—hypertension	1.66e-05	0.000179	CcSEcCtD
Solifenacin—Rash—Perindopril—hypertension	1.65e-05	0.000178	CcSEcCtD
Solifenacin—Dermatitis—Perindopril—hypertension	1.65e-05	0.000178	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Lisinopril—hypertension	1.65e-05	0.000177	CcSEcCtD
Solifenacin—Nausea—Telmisartan—hypertension	1.65e-05	0.000177	CcSEcCtD
Solifenacin—Fatigue—Lisinopril—hypertension	1.65e-05	0.000177	CcSEcCtD
Solifenacin—Vomiting—Hydrochlorothiazide—hypertension	1.65e-05	0.000177	CcSEcCtD
Solifenacin—Rash—Irbesartan—hypertension	1.65e-05	0.000177	CcSEcCtD
Solifenacin—Dermatitis—Irbesartan—hypertension	1.65e-05	0.000177	CcSEcCtD
Solifenacin—Headache—Perindopril—hypertension	1.64e-05	0.000177	CcSEcCtD
Solifenacin—Urticaria—Timolol—hypertension	1.64e-05	0.000176	CcSEcCtD
Solifenacin—Headache—Irbesartan—hypertension	1.64e-05	0.000176	CcSEcCtD
Solifenacin—Constipation—Lisinopril—hypertension	1.63e-05	0.000176	CcSEcCtD
Solifenacin—Rash—Hydrochlorothiazide—hypertension	1.63e-05	0.000176	CcSEcCtD
Solifenacin—Dermatitis—Hydrochlorothiazide—hypertension	1.63e-05	0.000175	CcSEcCtD
Solifenacin—Abdominal pain—Timolol—hypertension	1.63e-05	0.000175	CcSEcCtD
Solifenacin—Dizziness—Losartan—hypertension	1.63e-05	0.000175	CcSEcCtD
Solifenacin—Headache—Hydrochlorothiazide—hypertension	1.62e-05	0.000175	CcSEcCtD
Solifenacin—Vomiting—Furosemide—hypertension	1.62e-05	0.000174	CcSEcCtD
Solifenacin—Rash—Furosemide—hypertension	1.61e-05	0.000173	CcSEcCtD
Solifenacin—Dermatitis—Furosemide—hypertension	1.6e-05	0.000173	CcSEcCtD
Solifenacin—Vomiting—Betaxolol—hypertension	1.6e-05	0.000172	CcSEcCtD
Solifenacin—Nausea—Captopril—hypertension	1.6e-05	0.000172	CcSEcCtD
Solifenacin—Headache—Furosemide—hypertension	1.6e-05	0.000172	CcSEcCtD
Solifenacin—Rash—Betaxolol—hypertension	1.59e-05	0.000171	CcSEcCtD
Solifenacin—Dermatitis—Betaxolol—hypertension	1.59e-05	0.000171	CcSEcCtD
Solifenacin—Headache—Betaxolol—hypertension	1.58e-05	0.00017	CcSEcCtD
Solifenacin—Feeling abnormal—Lisinopril—hypertension	1.58e-05	0.000169	CcSEcCtD
Solifenacin—Gastrointestinal pain—Lisinopril—hypertension	1.56e-05	0.000168	CcSEcCtD
Solifenacin—Vomiting—Losartan—hypertension	1.56e-05	0.000168	CcSEcCtD
Solifenacin—Nausea—Perindopril—hypertension	1.56e-05	0.000167	CcSEcCtD
Solifenacin—Hypersensitivity—Ramipril—hypertension	1.55e-05	0.000167	CcSEcCtD
Solifenacin—Nausea—Irbesartan—hypertension	1.55e-05	0.000167	CcSEcCtD
Solifenacin—Rash—Losartan—hypertension	1.55e-05	0.000167	CcSEcCtD
Solifenacin—Dermatitis—Losartan—hypertension	1.55e-05	0.000167	CcSEcCtD
Solifenacin—Headache—Losartan—hypertension	1.54e-05	0.000166	CcSEcCtD
Solifenacin—Nausea—Hydrochlorothiazide—hypertension	1.54e-05	0.000165	CcSEcCtD
Solifenacin—Urticaria—Lisinopril—hypertension	1.52e-05	0.000163	CcSEcCtD
Solifenacin—Hypersensitivity—Timolol—hypertension	1.52e-05	0.000163	CcSEcCtD
Solifenacin—Nausea—Furosemide—hypertension	1.51e-05	0.000163	CcSEcCtD
Solifenacin—Asthenia—Ramipril—hypertension	1.51e-05	0.000163	CcSEcCtD
Solifenacin—Abdominal pain—Lisinopril—hypertension	1.51e-05	0.000163	CcSEcCtD
Solifenacin—Nausea—Betaxolol—hypertension	1.5e-05	0.000161	CcSEcCtD
Solifenacin—Pruritus—Ramipril—hypertension	1.49e-05	0.00016	CcSEcCtD
Solifenacin—Asthenia—Timolol—hypertension	1.48e-05	0.000159	CcSEcCtD
Solifenacin—Nausea—Losartan—hypertension	1.46e-05	0.000157	CcSEcCtD
Solifenacin—Pruritus—Timolol—hypertension	1.46e-05	0.000157	CcSEcCtD
Solifenacin—Hypersensitivity—Lisinopril—hypertension	1.41e-05	0.000151	CcSEcCtD
Solifenacin—Dizziness—Ramipril—hypertension	1.39e-05	0.00015	CcSEcCtD
Solifenacin—Asthenia—Lisinopril—hypertension	1.37e-05	0.000147	CcSEcCtD
Solifenacin—Dizziness—Timolol—hypertension	1.36e-05	0.000147	CcSEcCtD
Solifenacin—Pruritus—Lisinopril—hypertension	1.35e-05	0.000145	CcSEcCtD
Solifenacin—Vomiting—Ramipril—hypertension	1.34e-05	0.000144	CcSEcCtD
Solifenacin—Rash—Ramipril—hypertension	1.33e-05	0.000143	CcSEcCtD
Solifenacin—Dermatitis—Ramipril—hypertension	1.33e-05	0.000143	CcSEcCtD
Solifenacin—Headache—Ramipril—hypertension	1.32e-05	0.000142	CcSEcCtD
Solifenacin—Vomiting—Timolol—hypertension	1.31e-05	0.000141	CcSEcCtD
Solifenacin—Rash—Timolol—hypertension	1.3e-05	0.00014	CcSEcCtD
Solifenacin—Dermatitis—Timolol—hypertension	1.3e-05	0.00014	CcSEcCtD
Solifenacin—Headache—Timolol—hypertension	1.29e-05	0.000139	CcSEcCtD
Solifenacin—Dizziness—Lisinopril—hypertension	1.26e-05	0.000136	CcSEcCtD
Solifenacin—Nausea—Ramipril—hypertension	1.25e-05	0.000135	CcSEcCtD
Solifenacin—Nausea—Timolol—hypertension	1.22e-05	0.000132	CcSEcCtD
Solifenacin—Vomiting—Lisinopril—hypertension	1.22e-05	0.000131	CcSEcCtD
Solifenacin—Rash—Lisinopril—hypertension	1.21e-05	0.00013	CcSEcCtD
Solifenacin—Dermatitis—Lisinopril—hypertension	1.2e-05	0.000129	CcSEcCtD
Solifenacin—Headache—Lisinopril—hypertension	1.2e-05	0.000129	CcSEcCtD
Solifenacin—Nausea—Lisinopril—hypertension	1.14e-05	0.000122	CcSEcCtD
Solifenacin—CHRM1—Signaling Pathways—PRKCD—hypertension	1.59e-06	3.06e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCR5—hypertension	1.58e-06	3.05e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKCD—hypertension	1.58e-06	3.05e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCD—hypertension	1.57e-06	3.02e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCR5—hypertension	1.57e-06	3.02e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—FGF2—hypertension	1.56e-06	3e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2A—hypertension	1.55e-06	2.99e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RHOA—hypertension	1.55e-06	2.99e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—C3—hypertension	1.55e-06	2.99e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2A—hypertension	1.55e-06	2.98e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—C3—hypertension	1.55e-06	2.98e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOS3—hypertension	1.54e-06	2.96e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3R1—hypertension	1.54e-06	2.96e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2A—hypertension	1.53e-06	2.95e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—C3—hypertension	1.53e-06	2.95e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HSPG2—hypertension	1.53e-06	2.94e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RELA—hypertension	1.51e-06	2.91e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PDGFB—hypertension	1.51e-06	2.91e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PDGFB—hypertension	1.5e-06	2.9e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGFR1—hypertension	1.5e-06	2.89e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—hypertension	1.5e-06	2.89e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGFR1—hypertension	1.5e-06	2.88e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PDGFB—hypertension	1.49e-06	2.87e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGFR1—hypertension	1.48e-06	2.86e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MTOR—hypertension	1.48e-06	2.85e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HIF1A—hypertension	1.48e-06	2.85e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—POMC—hypertension	1.48e-06	2.85e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALOX5—hypertension	1.48e-06	2.84e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GLP1R—hypertension	1.48e-06	2.84e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HIF1A—hypertension	1.47e-06	2.84e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AGT—hypertension	1.47e-06	2.84e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—INS—hypertension	1.47e-06	2.83e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AGT—hypertension	1.47e-06	2.83e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HIF1A—hypertension	1.46e-06	2.81e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AGT—hypertension	1.45e-06	2.8e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CALM1—hypertension	1.45e-06	2.79e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RELA—hypertension	1.45e-06	2.79e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CALM1—hypertension	1.44e-06	2.78e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LEP—hypertension	1.44e-06	2.78e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOE—hypertension	1.44e-06	2.78e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOE—hypertension	1.44e-06	2.77e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LEP—hypertension	1.44e-06	2.77e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CAV1—hypertension	1.43e-06	2.76e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CALM1—hypertension	1.43e-06	2.76e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOA1—hypertension	1.43e-06	2.75e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CAV1—hypertension	1.43e-06	2.75e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LEP—hypertension	1.42e-06	2.75e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOE—hypertension	1.42e-06	2.75e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—hypertension	1.42e-06	2.74e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOA1—hypertension	1.42e-06	2.74e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MTOR—hypertension	1.42e-06	2.73e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KDR—hypertension	1.41e-06	2.73e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CAV1—hypertension	1.41e-06	2.72e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KDR—hypertension	1.41e-06	2.72e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOA1—hypertension	1.41e-06	2.71e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KDR—hypertension	1.4e-06	2.69e-05	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AKT1—hypertension	1.37e-06	2.65e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—hypertension	1.36e-06	2.63e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—F2—hypertension	1.36e-06	2.62e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FN1—hypertension	1.36e-06	2.62e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRKCB—hypertension	1.36e-06	2.62e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FN1—hypertension	1.36e-06	2.61e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—F2—hypertension	1.36e-06	2.61e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKCB—hypertension	1.36e-06	2.61e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—hypertension	1.35e-06	2.61e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALDH2—hypertension	1.35e-06	2.6e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—hypertension	1.35e-06	2.6e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FN1—hypertension	1.34e-06	2.59e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—F2—hypertension	1.34e-06	2.59e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCB—hypertension	1.34e-06	2.59e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOTCH1—hypertension	1.33e-06	2.57e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOTCH1—hypertension	1.33e-06	2.56e-05	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AKT1—hypertension	1.32e-06	2.54e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HBA1—hypertension	1.31e-06	2.53e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOTCH1—hypertension	1.31e-06	2.53e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP11A1—hypertension	1.31e-06	2.52e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—hypertension	1.3e-06	2.5e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NOS3—hypertension	1.29e-06	2.48e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3R1—hypertension	1.29e-06	2.48e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—hypertension	1.29e-06	2.48e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTT1—hypertension	1.28e-06	2.47e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SLC9A1—hypertension	1.28e-06	2.47e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN1A—hypertension	1.28e-06	2.47e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PTEN—hypertension	1.28e-06	2.47e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GCLC—hypertension	1.27e-06	2.45e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CETP—hypertension	1.27e-06	2.45e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK8—hypertension	1.25e-06	2.41e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AKT1—hypertension	1.25e-06	2.4e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—POMC—hypertension	1.24e-06	2.39e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—POMC—hypertension	1.24e-06	2.38e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—INS—hypertension	1.23e-06	2.38e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—hypertension	1.23e-06	2.37e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—INS—hypertension	1.23e-06	2.37e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN1A—hypertension	1.23e-06	2.37e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PTEN—hypertension	1.22e-06	2.36e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—POMC—hypertension	1.22e-06	2.36e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EP300—hypertension	1.22e-06	2.35e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—INS—hypertension	1.22e-06	2.35e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP17A1—hypertension	1.21e-06	2.34e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL2—hypertension	1.21e-06	2.34e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL2—hypertension	1.21e-06	2.33e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ENO1—hypertension	1.2e-06	2.32e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS1—hypertension	1.2e-06	2.32e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK8—hypertension	1.2e-06	2.31e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL2—hypertension	1.2e-06	2.31e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AKT1—hypertension	1.19e-06	2.3e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1—hypertension	1.19e-06	2.3e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT2—hypertension	1.19e-06	2.3e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1—hypertension	1.19e-06	2.29e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT2—hypertension	1.19e-06	2.29e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EGFR—hypertension	1.19e-06	2.29e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SRC—hypertension	1.19e-06	2.29e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EGFR—hypertension	1.18e-06	2.28e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—hypertension	1.18e-06	2.27e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1—hypertension	1.18e-06	2.27e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT2—hypertension	1.18e-06	2.27e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EGFR—hypertension	1.17e-06	2.26e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EP300—hypertension	1.17e-06	2.25e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CTGF—hypertension	1.16e-06	2.23e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—hypertension	1.16e-06	2.23e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT2—hypertension	1.15e-06	2.21e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMGCR—hypertension	1.15e-06	2.21e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SRC—hypertension	1.14e-06	2.19e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SERPINE1—hypertension	1.13e-06	2.18e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SERPINE1—hypertension	1.13e-06	2.18e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADRA2A—hypertension	1.12e-06	2.16e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SERPINE1—hypertension	1.12e-06	2.15e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—hypertension	1.11e-06	2.13e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGF2—hypertension	1.1e-06	2.11e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGF2—hypertension	1.09e-06	2.11e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RHOA—hypertension	1.09e-06	2.11e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RHOA—hypertension	1.09e-06	2.1e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGF2—hypertension	1.08e-06	2.09e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOS3—hypertension	1.08e-06	2.08e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3R1—hypertension	1.08e-06	2.08e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RHOA—hypertension	1.08e-06	2.08e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3R1—hypertension	1.08e-06	2.08e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOS3—hypertension	1.08e-06	2.08e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3R1—hypertension	1.07e-06	2.06e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOS3—hypertension	1.07e-06	2.06e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MYC—hypertension	1.06e-06	2.05e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TGFB1—hypertension	1.06e-06	2.04e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TH—hypertension	1.05e-06	2.03e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CALM2—hypertension	1.05e-06	2.02e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EGFR—hypertension	1.04e-06	2e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTEN—hypertension	1.03e-06	1.98e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GCG—hypertension	1.02e-06	1.97e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SLC2A4—hypertension	1.02e-06	1.97e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MYC—hypertension	1.02e-06	1.96e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RELA—hypertension	1.02e-06	1.96e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TGFB1—hypertension	1.02e-06	1.96e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RELA—hypertension	1.01e-06	1.96e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RELA—hypertension	1e-06	1.94e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MTOR—hypertension	9.98e-07	1.92e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EGFR—hypertension	9.96e-07	1.92e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MTOR—hypertension	9.95e-07	1.92e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT1—hypertension	9.9e-07	1.91e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MTOR—hypertension	9.85e-07	1.9e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—EP300—hypertension	9.8e-07	1.89e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—STK11—hypertension	9.61e-07	1.85e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP19A1—hypertension	9.61e-07	1.85e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—hypertension	9.59e-07	1.85e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—hypertension	9.56e-07	1.84e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—hypertension	9.47e-07	1.82e-05	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AKT1—hypertension	9.26e-07	1.79e-05	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AKT1—hypertension	9.23e-07	1.78e-05	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AKT1—hypertension	9.15e-07	1.76e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—hypertension	9.12e-07	1.76e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—hypertension	9.09e-07	1.75e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—hypertension	9e-07	1.74e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—COMT—hypertension	8.94e-07	1.72e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GNB3—hypertension	8.81e-07	1.7e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARGC1A—hypertension	8.81e-07	1.7e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMOX1—hypertension	8.77e-07	1.69e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—hypertension	8.73e-07	1.68e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—hypertension	8.67e-07	1.67e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAT—hypertension	8.66e-07	1.67e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—hypertension	8.65e-07	1.67e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN1A—hypertension	8.64e-07	1.67e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTEN—hypertension	8.62e-07	1.66e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN1A—hypertension	8.62e-07	1.66e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTEN—hypertension	8.6e-07	1.66e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GNAS—hypertension	8.58e-07	1.65e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—hypertension	8.56e-07	1.65e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN1A—hypertension	8.53e-07	1.64e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTEN—hypertension	8.51e-07	1.64e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK8—hypertension	8.44e-07	1.63e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AKT1—hypertension	8.41e-07	1.62e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK8—hypertension	8.41e-07	1.62e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOB—hypertension	8.4e-07	1.62e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AKT1—hypertension	8.39e-07	1.62e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—hypertension	8.36e-07	1.61e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK8—hypertension	8.33e-07	1.61e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AKT1—hypertension	8.3e-07	1.6e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EP300—hypertension	8.22e-07	1.59e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EP300—hypertension	8.2e-07	1.58e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTM1—hypertension	8.17e-07	1.58e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EP300—hypertension	8.12e-07	1.56e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LPL—hypertension	8.02e-07	1.55e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SRC—hypertension	8e-07	1.54e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—hypertension	7.99e-07	1.54e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SRC—hypertension	7.97e-07	1.54e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SRC—hypertension	7.89e-07	1.52e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADCY5—hypertension	7.85e-07	1.51e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GPX1—hypertension	7.83e-07	1.51e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—hypertension	7.79e-07	1.5e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—hypertension	7.76e-07	1.5e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PRKCA—hypertension	7.75e-07	1.49e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP1A1—hypertension	7.75e-07	1.49e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—hypertension	7.69e-07	1.48e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—hypertension	7.65e-07	1.47e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CD36—hypertension	7.62e-07	1.47e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT1—hypertension	7.37e-07	1.42e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—hypertension	7.22e-07	1.39e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MYC—hypertension	7.17e-07	1.38e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TGFB1—hypertension	7.15e-07	1.38e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MYC—hypertension	7.14e-07	1.38e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TGFB1—hypertension	7.13e-07	1.37e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARA—hypertension	7.09e-07	1.37e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MYC—hypertension	7.07e-07	1.36e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT1—hypertension	7.06e-07	1.36e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TGFB1—hypertension	7.06e-07	1.36e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGFR—hypertension	7.01e-07	1.35e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGFR—hypertension	6.99e-07	1.35e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGFR—hypertension	6.92e-07	1.33e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AGT—hypertension	6.86e-07	1.32e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CALM1—hypertension	6.75e-07	1.3e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOE—hypertension	6.73e-07	1.3e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAV1—hypertension	6.66e-07	1.28e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOA1—hypertension	6.65e-07	1.28e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AKT1—hypertension	5.92e-07	1.14e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—hypertension	5.89e-07	1.13e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—hypertension	5.87e-07	1.13e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—hypertension	5.86e-07	1.13e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—hypertension	5.81e-07	1.12e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—POMC—hypertension	5.78e-07	1.11e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—INS—hypertension	5.75e-07	1.11e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—hypertension	5.39e-07	1.04e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—hypertension	5.37e-07	1.04e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—hypertension	5.32e-07	1.03e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—hypertension	5.27e-07	1.02e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NOS3—hypertension	5.04e-07	9.71e-06	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3R1—hypertension	5.04e-07	9.71e-06	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT1—hypertension	4.97e-07	9.58e-06	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT1—hypertension	4.95e-07	9.55e-06	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT1—hypertension	4.91e-07	9.46e-06	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—hypertension	4.61e-07	8.88e-06	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTEN—hypertension	4.02e-07	7.75e-06	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—EP300—hypertension	3.83e-07	7.39e-06	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKT1—hypertension	2.32e-07	4.46e-06	CbGpPWpGaD
